CDT Equity Inc. (CDTTW)Naples, United States | NasdaqCM
0.01 USD
+0.00
(107.407%)
⇧
(Oct. 13, 2026, 3:50 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 6:53 a.m. EDT
The security is trading at a floor level of $0.01 with zero price history available to assess trends, creating a stalemate where capital is effectively trapped. Fundamentally, the company is in severe distress with a current ratio of 0.126, indicating severe liquidity constraints, and negative returns on both assets and equity. The balance sheet is impaired with debt exceeding cash reserves, and operating cash flow is negative, signaling an inability to sustain core operations without external financing. There is no dividend distribution, offering no income buffer. While free cash flow appears positive, the negative operating cash flow suggests accounting anomalies or non-recurring items that do not reflect sustainable earnings power. With no analyst coverage, no historical price trajectory to validate business quality, and a market structure suggesting a potential delisting or halt, the investment case is nonexistent. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 1.147 |
| Beta | 1.56 |
| Previous Name | Conduit Pharmaceuticals Inc. |
| Website | https://www.cdtequity.com |
| Attribute | Value |
|---|---|
| Address1 | 4,581 Tamiami Trail North |
| Address2 | Suite 200 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 1.556 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 4,084.023 |
| City | Naples |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0056 |
| Current Ratio | 0.126 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0073 |
| Day Low | 0.0056 |
| Debt To Equity | 1.147 |
| Ebitda | -22,833,000 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0073 |
| Fifty Two Week High Change | -0.0017000004 |
| Fifty Two Week High Change Percent | -0.23287676 |
| Fifty Two Week Low | 0.0056 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 0.0056 - 0.0073 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 21,023 |
| Free Cashflow | 19,616,876 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 4 |
| Fullday Change | 0.0028999997 |
| Fullday Change Percent | 107.40739 |
| Fullday Price | 0.0056 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Language | en-US |
| Long Business Summary | CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida. |
| Long Name | CDT Equity Inc. |
| Market | us_market |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_1772079937 |
| Name Change Date | 2,026-10-14 |
| Net Income To Common | -37,147,000 |
| Open | 0.0119 |
| Operating Cashflow | -11,484,000 |
| Operating Margins | 0.0 |
| Phone | 646 491 9132 |
| Prev Name | Conduit Pharmaceuticals Inc. |
| Previous Close | 0.0027 |
| Price Hint | 4 |
| Price To Book | 0.000001371197 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.039 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0028999997 |
| Regular Market Change Percent | 107.407394 |
| Regular Market Day High | 0.0073 |
| Regular Market Day Low | 0.0056 |
| Regular Market Day Range | 0.0056 - 0.0073 |
| Regular Market Open | 0.0119 |
| Regular Market Previous Close | 0.0027 |
| Regular Market Price | 0.0056 |
| Regular Market Time | 1,791,921,018 |
| Regular Market Volume | 28,551 |
| Return On Assets | -0.23435 |
| Return On Equity | -0.6968 |
| Sand P52 Week Change | 0.17502642 |
| Sector | |
| Sector Key | |
| Source Interval | 15 |
| State | FL |
| Symbol | CDTTW |
| Total Cash | 747,000 |
| Total Cash Per Share | 23.739 |
| Total Debt | 1,182,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 28,551 |
| Website | https://www.cdtequity.com |
| Zip | 34,103 |